Toxicogenomic analysis methods for predictive toxicology

Journal of Pharmacological and Toxicological Methods

Volumn 53, Issue 1, 2006, Pages 31-37

  Maggioli, Jeff ^a   Hoover, Aubree ^a   Weng, Lee ^a  

^a Rosetta Biosoftware   (United States)

Author keywords

Gene expression; Predictive toxicology; Review; Toxicogenomics

Indexed keywords

3 METHYLCHOLANTHRENE; ALLYL ALCOHOL; AMIODARONE; AROCLOR; ARSENIC; CARBAMAZEPINE; CARBON TETRACHLORIDE; DIETHYLFORMAMIDE; DIETHYLNITROSAMINE; DIQUAT; ETOPOSIDE; FORMAMIDE DERIVATIVE; INDOMETACIN; METHAPYRILENE; METHOTREXATE; MONOCROTALINE; UNCLASSIFIED DRUG;

CLUSTER ANALYSIS; DRUG RESEARCH; GENE CLUSTER; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC SELECTION; LIVER TOXICITY; MATHEMATICAL MODEL; NONHUMAN; PREDICTION; REVIEW; STATISTICAL ANALYSIS; TOXICOGENETICS;

EID: 30144445804     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2005.05.006     Document Type: Article

References (15)

1. C.A. Afshari, E.F. Nuwaysir, and J.C. Barrett Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation Cancer Research 59 1999 4759 4760
2. P. Baldi, and W. Hatfield DNA microarrays and gene expression 2002 Cambridge University Press Cambridge, UK
3. S. Dudoit, J. Fridlyand, and T.P. Speed Comparison of discrimination methods for the classification of tumors using gene expression data Journal of the American Statistical Association 97 2002 77 87
4. H.K. Hamadeh, P.R. Bushel, S. Jayadev, O. DiSorbo, L. Bennett, and L. Li Prediction of compound signature using high density gene expression profiling Toxicological Sciences 67 2002 232 240
5. H.K. Hamadeh, P.R. Bushel, S. Jayadev, K. Martin, O. DiSorbo, and S. Sieber Gene expression analysis reveals chemical-specific profiles Toxicological Sciences 67 2002 219 231
6. K.R. Hayes, A.L. Vollrath, G.M. Zastrow, B.J. McMillian, M. Craven, and S. Jovanovich EDGE: A centralized resource for the comparison, analysis, and distribution of toxicogenomic information Molecular Pharmacology 67 2005 1360 1368
7. A. Lühe, L. Suter, S. Ruepp, T. Singer, T. Weiser, and S. Albertini Toxicogenomics in the pharmaceutical industry: Hollow promises or real benefit? Mutation Research 575 1-2 2005 102 115
8. F. Pognan Genomics, proteomics and metabonomics in toxicology: Hopefully not 'fashionomics' Pharmacogenomics 5 7 2004 879 893
9. R. Simon, M.D. Radmacher, K. Dobbin, and L.M. McShane Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification Journal of the National Cancer Institute 95 2003 14 18
10. R.S. Thomas, D.R. Rank, S.G. Penn, G.M. Zastrow, K.R. Hayes, and K. Pande Identification of toxicologically predictive gene sets using cDNA microarrays Molecular Pharmacology 60 2001 1189 1194
11. C.A. Tsai, T.C. Lee, I.C. Ho, U.C. Yang, C.H. Chen, and J.J. Chen Multi-class clustering and prediction in the analysis of microarray data Mathematical Biosciences 193 2005 79 100
12. R. Ulrich, and S. Friend Toxicogenomics and drug discovery: Will new technologies help us produce better drugs? Nature Reviews Drug Discovery 1 2001 84 88
13. J.H.M. Van Delft, E. van Agen, S.G.J. van Breda, M.H. Herwijnen, Y.C.M. Staal, and J.C.S. Kleinjans Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling Mutation Research 575 2005 1 3
14. J.F. Waring, R.A. Jolly, R. Ciurlionis, P.Y. Lum, J.T. Praestgaard, and D.C. Morfitt Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles Toxicology and Applied Pharmacology 175 2001 28 42
15. Y. Yang, E.A. Blomme, and J.F. Waring Toxicogenomics in drug discovery: From preclinical studies to clinical trials Chemico-Biological Interactions 150 2004 71 85